At Retrace, our mission is to improve the quality of global healthcare through the use of intelligent medicine. Our products enable our partners and customers to unlock the full potential of their data.
Pioneering Intelligent Healthcare
The Retrace Solution
With the push of a button, clinicians will have access to a collective knowledge of millions of doctors. Retrace allows doctors to make data driven decisions and benefit from AI enhanced virtual collogues. Retrace provides expert second opinions that are adaptable to each doctor and learn to be complementary to the specific clinical tendencies of each practice.
Intelligent Data Ecosystem
Security, Integrity, and Ethics
Secure Intelligent Medicine
Accelerate The Development of AI with Retrace
Retrace aggregates the collective knowledge of medical and dental thought leaders throughout the world through a cryptographically secure data pipeline that is flexible and nimble enough to delivery directly to our partners.
Retrace is spearheading the predictive medical and dental paradigm shift
Situated in the heart of San Francisco, Retrace is at the forefront of artificial intelligence innovation in medicine and dentistry. Retrace has many medical and dental AI incentives focusing on a broad range of technologies. We have partnered with the leading academic institutions in the world to bring a complementary blend of precision medicine to our partners.
Career Opportunities with Retrace
At Retrace the very best ideas win. Ideal team members will possess a mixture of raw talent, scientific skepticism, and playful creativity. Retrace helps support developing talent through scholarships and grants within the AI, computer science, and healthcare communities.
Research & Resources
Retrace honors science and is supportive of academic publications for our team members, partners, and grant recipients in dentistry and medicine.
Retrace has a very active and expansive IP portfolio and we encourage our core team members to participate in patent writing and prosecution. Retrace believes that good ideas should benefit all of humanity, which is why our IP strategy is purely defensive.